Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.

about

Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance Interleukin 35 induced Th2 and Tregs bias under normal conditions in mice

P2860

Q58695273-A4D81720-0C53-4767-8956-A9FFADC35D3B Q58706304-3286468F-C3F7-4C60-8149-3B51521D5513

P2860

Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.

Item

http://www.wikidata.org/entity/Q47829774

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Mesenchymal Stem Cells Overexp ...... nosuppressive Effects in Mice.

@en

Mesenchymal Stem Cells Overexp ...... nosuppressive Effects in Mice.

@nl

type

Item

label

Mesenchymal Stem Cells Overexp ...... nosuppressive Effects in Mice.

@en

Mesenchymal Stem Cells Overexp ...... nosuppressive Effects in Mice.

@nl

prefLabel

Mesenchymal Stem Cells Overexp ...... nosuppressive Effects in Mice.

@en

Mesenchymal Stem Cells Overexp ...... nosuppressive Effects in Mice.

@nl

P1476

Mesenchymal Stem Cells Overexp ...... unosuppressive Effects in Mice

@en

P2093

H Gao

http://www.w3.org/2001/XMLSchema#string

N Zhao

http://www.w3.org/2001/XMLSchema#string

X He

http://www.w3.org/2001/XMLSchema#string

P2860

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

IL-12 family cytokines: immunological playmakers

IL-35-mediated induction of a potent regulatory T cell population.

IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease

Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice.

Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis

Foxp3-modified bone marrow mesenchymal stem cells promotes liver allograft tolerance through the generation of regulatory T cells in rats

P304

389-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/SJI.12613

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

H Guo

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28888053

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.

about

P2860

P2860

Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921